Market closedNon-fractional
Innoviva/INVA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Innoviva
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Ticker
INVA
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Burlingame, United States
Employees
112
Website
www.inva.com
Innoviva Metrics
BasicAdvanced
$1.1B
Market cap
8.07
P/E ratio
$2.25
EPS
0.58
Beta
-
Dividend rate
Price and volume
Market cap
$1.1B
Beta
0.58
Financial strength
Current ratio
10.42
Quick ratio
8.513
Long term debt to equity
63.489
Total debt to equity
63.489
Interest coverage (TTM)
6.65%
Management effectiveness
Return on assets (TTM)
7.14%
Return on equity (TTM)
28.67%
Valuation
Price to earnings (TTM)
8.073
Price to revenue (TTM)
3.753
Price to book
1.63
Price to tangible book (TTM)
2.49
Price to free cash flow (TTM)
7.691
Growth
Revenue change (TTM)
-1.91%
Earnings per share change (TTM)
-13.24%
3-year revenue growth (CAGR)
-3.21%
3-year earnings per share growth (CAGR)
-0.25%
What the Analysts think about Innoviva
Analyst Ratings
Majority rating from 1 analysts.
Innoviva Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$77M
-9.79%
Net income
$37M
-40.65%
Profit margin
47.15%
-34.21%
Innoviva Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.02
$0.98
$0.76
$0.46
-
Expected
$0.26
$0.27
$0.23
$0.17
$0.25
Surprise
-92.31%
262.96%
230.43%
170.59%
-
Innoviva News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Innoviva stock?
Innoviva (INVA) has a market cap of $1.1B as of July 27, 2024.
What is the P/E ratio for Innoviva stock?
The price to earnings (P/E) ratio for Innoviva (INVA) stock is 8.07 as of July 27, 2024.
Does Innoviva stock pay dividends?
No, Innoviva (INVA) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Innoviva dividend payment date?
Innoviva (INVA) stock does not pay dividends to its shareholders.
What is the beta indicator for Innoviva?
Innoviva (INVA) has a beta rating of 0.58. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Innoviva stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.